Galectin Therapeutics Provides Phase 2 NASH Program Update and Reports Second Quarter 2015 Financial Results

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/23/2026

1. ABBV
2. MU
3. IBM
4. SPCX
5. ACN
6. NVDA
7. PRIM
8. META
9. SPY
10. DPZ

Go back to Galectin Therapeutics Provides Phase 2 NASH Program Update and Reports Second Quarter 2015 Financial Results
GALECTIN (NASDAQ: GALT) Delayed: 3.15 +0.35 (12.50%)
Previous Close $2.80    52 Week High $3.05 
Open $2.71    52 Week Low $0.49 
Day High $3.19    P/E N/A 
Day Low $2.71    EPS $-1.32 
Volume 313,997